Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by Δ9,-THC and other cannabinoids

Pharmacology Biochemistry and Behavior

Volumn 71, Issue 1-2, 2002, Pages 155-162

  Janoyan, Jano J ^a   Crim, Jennifer L ^a   Darmani, Nissar A ^a  

^a A T STILL UNIVERSITY   (United States)

Author keywords

8 THC; 9 THC; CP 55, 940; Ear scratch response; Head twitch response; HU 210; Locomotor activity; Rearing; WIN 55, 212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID DERIVATIVE; DELTA8 TETRAHYDROCANNABINOL; DEXANABINOL; DRONABINOL; EL 620; EPLIVANSERIN; RICINOMACROGOL; RIMONABANT; SEROTONIN 2A AGONIST; SEROTONIN 2C AGONIST; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG POTENCY; DRUG SCREENING; DRUG SELECTIVITY; FREQUENCY MODULATION; HEAD TWITCH; LOCOMOTION; MALE; MEDICAL ASSESSMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECORDING; SCRATCHING;

ANALGESICS, NON-NARCOTIC; ANIMALS; BEHAVIOR, ANIMAL; CANNABINOIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; PIPERIDINES; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAHYDROCANNABINOL;

EID: 0037006058     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(01)00647-5     Document Type: Article

References (33)

1. Neurobiology of marijuana abuse
2. 9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication
3. 2 receptor mediated behavior in the rat by oleamide and the role of cannabinoid receptors
4. 9-tetrahydrocannabinol
5. Pharmacological profile of a series of bicyclic cannabinoid analogs: Classification as cannabimimetic agents
6. Cannabinoid structure-activity relationships; correlation of receptor binding and in vivo activities
7. 9-tetrahydrocannabinol-induced responses and apparent agonist activity
8. 9-tetrahydrocannabinol
9. 1 receptors in the least shrew
10. 2A receptor-mediated behaviors in mice
11. 1 receptor antagonist/inverse agonist SR 141716A
12. 1 receptor antagonist SR 141716A in naive mice
13. 2 receptors?
14. 2-receptor interaction
15. 3 receptors in rat nodose ganglion neurons
16. 2A receptor are insensitive to many of the behavioral and physiological effects of hallucinogens
17. Cannabinoid receptors and their role in the regulation of the serotonin transporter in human placenta
18. Changes in 5-HT receptor binding induced by tetrahydrocannabinol metabolites in bovine cerebral cortex
19. Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor
20. The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antininoception in rats
21. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice
22. 8-THC-dimethylheptyl in mice and dogs
23. Pharmacological activity of delta-9-THC metabolites and analogs of CBD, delta-8-THC and delta-9-THC
24. Cannabinoid geometry and biological activity
25. 9-tetrahydrocannabinol treatments
26. 1 receptors
27. 2 receptors
28. Cannabis and cannabinoids: Pharmacology and rationale clinical use
29. Structure-activity relationships in cannabinoids
30. SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor
31. 2 cannabinoid receptor
32. Cannabinoids block release of serotonin from platelets induced by plasma from migraine patients
33. 2A receptor agonists into the prefrontal cortex produces a head-twitch response in rats